Standout Papers

Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumo... 1998 2026 2007 2016 530
  1. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. (1998)
    Tetsuya Kubota, Kozo Koshizuka et al. PubMed

Immediate Impact

2 by Nobel laureates 28 from Science/Nature 63 standout
Sub-graph 1 of 23

Citing Papers

Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
2023 Standout
Complex scaffold remodeling in plant triterpene biosynthesis
2023 StandoutScience
2 intermediate papers

Works of Izuru Miyoshi being referenced

Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimerâs disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation study
2013
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
1998 Standout

Author Peers

Author Last Decade Papers Cites
Izuru Miyoshi 483 89 120 271 156 15 897
S. Leigh Verbois 396 103 144 104 68 9 1.1k
Alberto Chiappe 243 35 57 122 82 8 936
Zhenlei Xia 416 128 23 212 83 17 1.0k
Leah M. Hesse 240 39 65 40 137 21 1.1k
Jouni Vuorinen 82 103 52 116 74 28 834
Tara A. Macey 557 522 148 87 131 22 1.0k
Cheng-Kuei Chang 245 76 31 60 72 31 753
Cristina Morsiani 397 21 51 196 26 19 1.1k
Emily White 282 14 102 95 37 17 1.0k
Manuel Barrios 442 188 159 64 21 26 1.1k

All Works

Loading papers...

Rankless by CCL
2026